Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MPNST”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT03880123
What this trial is testing

Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma

Who this might be right for
LiposarcomaMalignant Peripheral Nerve Sheath TumorsAlveolar Soft Part Sarcoma+2 more
Matthew Ingham
Early research (Phase 1)Study completedNCT02700230
What this trial is testing

Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery

Who this might be right for
Metastatic Malignant Peripheral Nerve Sheath TumorNeurofibromatosis Type 1Recurrent Malignant Peripheral Nerve Sheath Tumor
Mayo Clinic 9
Testing effectiveness (Phase 2)Study completedNCT00526149
What this trial is testing

BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors

Who this might be right for
Breast CancerEndometrial CancerHead and Neck Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 76
Not applicableUnknownNCT01218139
What this trial is testing

Analysis of Peripheral Nerve Sheath Tumors (PNSTs) in Neurofibromatosis Type 1 (NF1) Patients

Who this might be right for
Neurofibromatosis Type 1
KU Leuven 50
Testing effectiveness (Phase 2)Study completedNCT01532687
What this trial is testing

Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma

Who this might be right for
Adult Alveolar Soft Part SarcomaAdult AngiosarcomaAdult Desmoplastic Small Round Cell Tumor+16 more
OHSU Knight Cancer Institute 54
Early research (Phase 1)Active Not RecruitingNCT04420975
What this trial is testing

Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma

Who this might be right for
LeiomyosarcomaMalignant Peripheral Nerve Sheath TumorMyxofibrosarcoma+27 more
Jonsson Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)Study completedNCT00041236
What this trial is testing

Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 39
Testing effectiveness (Phase 2)Ended earlyNCT02601209
What this trial is testing

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

Who this might be right for
High Grade SarcomaMetastatic LeiomyosarcomaMetastatic Malignant Peripheral Nerve Sheath Tumor+16 more
National Cancer Institute (NCI) 151
Testing effectiveness (Phase 2)UnknownNCT00003718
What this trial is testing

Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerOvarian CancerSarcoma
Herbert Irving Comprehensive Cancer Center 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Testing effectiveness (Phase 2)Ended earlyNCT00740597
What this trial is testing

Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma

Who this might be right for
Sarcoma
City of Hope Medical Center 1
Testing effectiveness (Phase 2)Study completedNCT00304083
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Neurofibromatosis Type 1Sarcoma
Sarcoma Alliance for Research through Collaboration 48
Not applicableAvailableNCT04091295
What this trial is testing

BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast

Who this might be right for
Pancreatic CancerOsteosarcomaMPNST (Malignant Peripheral Nerve Sheath Tumor)+6 more
Aveni Foundation
Testing effectiveness (Phase 2)Looking for participantsNCT05732831
What this trial is testing

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

Who this might be right for
Locally Advanced Solid Tumor
Tango Therapeutics, Inc. 225
Not applicableUnknownNCT00900211
What this trial is testing

Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX

Who this might be right for
Sarcoma
The Christie NHS Foundation Trust 400
Large-scale testing (Phase 3)Study completedNCT00002641
What this trial is testing

Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerKidney CancerOvarian Cancer+2 more
European Organisation for Research and Treatment of Cancer - EORTC 350
Early research (Phase 1)Looking for participantsNCT06041516
What this trial is testing

A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Neuroendocrine CarcinomasNeuroendocrine TumorsCarcinoma, Neuroendocrine+2 more
National Cancer Institute (NCI) 70
Early research (Phase 1)Study completedNCT04465643
What this trial is testing

Neoadjuvant Nivolumab Plus Ipilimumab for Newly Diagnosed Malignant Peripheral Nerve Sheath Tumor

Who this might be right for
Nerve Sheath Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 13
Not applicableStudy completedNCT00346125
What this trial is testing

PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Masonic Cancer Center, University of Minnesota 70
Testing effectiveness (Phase 2)UnknownNCT03651375
What this trial is testing

Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall

Who this might be right for
SarcomaFibrosarcomaLeiomyosarcoma+14 more
Maria Sklodowska-Curie National Research Institute of Oncology 46
Next Page